Novel insight into the dangerous connection between diabetes and heart failure

C Lombardi1, V Spigoni2, E Gorga2

  • 1Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Parma and AOU of Parma, Parma, Italy.

Herz
|April 14, 2016
PubMed

Insights

Diabetes mellitus (DM) is a common comorbidity in heart failure (HF), worsening patient outcomes. Diabetic cardiomyopathy involves fibrosis driven by neurohormonal changes, impacting HF progression and type.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pathophysiology

Background:

  • Heart failure (HF) affects 1-2% of adults, with diabetes mellitus (DM) as a frequent, prognostically negative comorbidity.
  • DM increases the risk of artery disease and post-ischemic HF, and can directly impair myocardial structure and function.

Purpose of the Study:

  • To elucidate the pathophysiological mechanisms of diabetic cardiomyopathy.
  • To understand the role of fibrosis in disease progression and HF phenotype determination.

Main Methods:

  • Review of experimental and clinical investigations into diabetic cardiomyopathy.
  • Analysis of neurohormonal alterations contributing to fibrotic processes.

Main Results:

  • Fibrosis is identified as a key consequence of converging neurohormonal alterations in diabetic cardiomyopathy.
  • These fibrotic changes are fundamental to disease progression and the development of HF with reduced or preserved ejection fraction.

Conclusions:

  • Understanding the fibrotic mechanisms in diabetic cardiomyopathy is crucial for managing co-existing HF and DM.
  • Future therapies for HF and DM should aim to improve prognosis while maintaining glucose homeostasis and preventing HF development.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
653